跳至主要内容
临床试验/JPRN-UMIN000027770
JPRN-UMIN000027770招募中1 期

Phase I/Ib study of Ad-SGE-REIC-GH in patient with liver cancer. - Phase I study of Ad-SGE-REIC-GH in patient with liver cancer.

Okayama University Hospital0 个研究点目标入组 12 人开始时间: 2017年6月20日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patient with active bacterial, fungal or viral infections. Hepatitis B or C is allowed Patient with brain metastasis Patient with other malignancies HIV-positive Patient with angina pectoris, congestive heart failure, or myocardial infarction less than 1 year previously Patient with psychiatric illness that would limit compliance with study requirements Pregnant women, women suspect she is pregnant, or lactating woman Patient have a history of allergic reactions against drugs used in this study Any experimental anti-cancer drug therapy within 4weeks prior to this study Any anti-cancer drug therapy within 4 weeks prior to this study Patient received topical therapy within 4 weeks prior to this study Patient on anticoagulation or antiplatelet therapy Poor glycemic control measured as HbA1C >8.0 Patient is on chronic systemic steroid therapy

研究者

相似试验